Uniting payors, providers, and pharmacies for seamless care.
53M+
Members supported
100%
Compliance Rate
- Strategy
- Web
- App
Most device software does not fail in the lab. It fails at submission, when the design history file is rebuilt in a rush, the safety class cannot be justified, or nobody can list the third-party code inside. Ailoitte is a medical device software development company that builds SaMD, embedded and AI device software to IEC 62304 and ISO 14971, with the evidence produced as we build, on a fixed price.
NDA first, and a BAA where patient data is involved. A senior engineer replies within one business day.
IEC 62304 Class A to C
Class justified from your hazard analysis.
Design file built as we go
Not rebuilt before submission.
SBOM on every build
Ready for FDA cyber review.
SaMD, embedded firmware, AI device software, companion apps, cloud back ends and clinician review tools.
Class A software to a validated release in about 4 to 6 months. Class B with a full design file in 8 to 14 months.
From about $60,000 for a Class A SaMD MVP to $350,000 or more for Class C or complex embedded work, fixed after scoping.
IEC 62304, ISO 14971, ISO 13485, IEC 62366-1, the FDA QMSR and cyber rules, and EU MDR and IVDR.
Bluetooth devices, HealthKit and Health Connect, EHRs over FHIR, DICOM imaging and cloud IoT platforms.
Code, design history file, risk file, test records and traceability, all assigned to you on payment.
Medical device software development is the design, build, testing and documentation of software that is a medical device, runs inside one, or supports one. It follows IEC 62304 for the software lifecycle, ISO 14971 for risk, ISO 13485 for quality and IEC 62366-1 for usability.
There are three kinds. SaMD does a medical job on its own, such as an app that reads an ECG. SiMD runs inside the hardware and makes it work. Supporting software covers companion apps, cloud back ends and production tools. Which one you build decides your regulatory path.
The rules now sit closer together. Since 2 February 2026, the FDA’s quality rule builds ISO 13485 straight into US law (FDA). One well-kept quality system can now serve both FDA and EU reviewers.
Our medical device software development services produce that evidence as part of the build. Plan for about 30 to 50 percent more engineering effort than similar unregulated software. For the wider platforms around a device, see healthcare software development and IoT development.
Describe the intended use and what could go wrong. A senior engineer will give you an honest first read, free.
Six problems cause more late rework in medical device software than any bug. We build the fix for each into the process from the first sprint, so your documentation, safety class and SOUP records are ready when the auditor asks.
The problem. Documents are written months after the code, so they disagree with it. Auditors spot that at once.
What fixes it. The design history file grows sprint by sprint, generated from the same tools as the code.
The problem. A team hopes for Class A to cut scope, and the reviewer asks for the reasoning.
What fixes it. Class set from the hazard analysis, with segregation used to lower it only where the design allows.
The problem. A library added in month two needs SOUP records that nobody wrote by month ten.
What fixes it. A SOUP inventory kept from the first commit, updated automatically on every change.
The problem. Links from hazards to tests break as the product changes, and gaps appear at submission.
What fixes it. Traceability kept in tooling tied to the repository, so the matrix is a report, not a project.
The problem. FDA cyber guidance, updated in February 2026, expects threat models and an SBOM in the submission (FDA).
What fixes it. Threat model in the risk file from the start, and an SBOM produced by every build.
The problem. The first device was hard-coded, so each new variant costs almost as much as the first.
What fixes it. A device abstraction layer, so a new model is configuration plus a verification pass.
From a submission-ready glucose monitor to wearable data platforms. Judge any medical device software development company on work you can read about. Browse all case studies.
Share the intended use, likely class and target markets. We will reply with an approach, a timeline and a fixed price.
Nine service lines across the device, the app and the cloud. Every one ships with the records your class requires, so the software and its evidence arrive together.
Standalone software with a medical purpose, built to its class with the full lifecycle file.
On-device software with real-time limits, safety functions and IEC 60601-1 in mind.
Model pipelines, versioned releases ready for a change control plan, and drift monitoring.
Bluetooth pairing, calibration, firmware updates and patient data views on iOS and Android.
Device data intake, fleet management, update rollout and analytics ready for postmarket review.
Reading and reporting screens designed against use-related risk under IEC 62366-1.
Test plans, protocols, run records and the traceability matrix, by our QA team.
Threat model, SBOM, vulnerability process and signed updates, ready for premarket review.
Bringing fielded software into a documented, defensible state, including SOUP records after the fact.
Engineers, quality leads and clinicians need different outputs from the same project. We plan all three from the first sprint.
Four habits that keep the software, the evidence and the schedule in step.
The class follows the risk, even when the answer is inconvenient. An unjustified class unravels the whole file later.
Requirements, risk links, tests and records are produced in each sprint, so nothing is rebuilt before submission.
Dependencies are tracked automatically and checked against known vulnerabilities from the first commit.
Your ISO 13485 procedures, templates and document control, or ours when you do not have one yet. Our process is open to your audit.
The code is rarely the problem. The discipline around it is. A team that ships good consumer apps can still struggle here, because device evidence cannot be added afterwards.
| On | General app vendor | Device software partner |
|---|---|---|
| Documentation | Written at the end, if at all. | Produced each sprint as part of done. |
| Safety class | Taken from the brief. | Justified from the hazard analysis. |
| Third-party code | Added freely, recorded later. | SOUP records and SBOM from the first commit. |
| Cybersecurity | A penetration test before launch. | Threat model in the risk file, plus a patch process. |
| Leaving the vendor | Hard, because only they know the file. | Easy: documented code, full file and a handover. |
We build device software for companies in the USA, UK, UAE, Australia, Canada, Europe and India. The right set depends on your device, class and markets, so we confirm it in discovery. See our security and compliance practices and HIPAA compliant software development.
FDA, EU MDR or both changes the file and the order of work. We plan the route with your regulatory lead before design.
Device data is worth more inside the systems clinicians already use. See EHR and EMR software development and wearable app development.
Pairing, bonding, GATT profiles and reconnection, with handling for missed readings.
Wi-Fi, NB-IoT and LTE-M for devices that report without a phone nearby.
Phone health data with consent for each data type on iOS and Android.
Device readings written to the record as coded observations, with HL7 v2 where needed.
Imaging studies retrieved and stored against the right patient and order.
AWS IoT Core or Azure IoT Hub for device registry, telemetry and update rollout.
The FDA has now authorised more than 1,600 AI-enabled devices. The hard part is rarely the model. It is updating it after clearance, so we design for that from the start. Our rule: AI informs, the clinician decides.
A Predetermined Change Control Plan lets you describe future model updates in the first submission. We build so one is workable.
A locked model acts the same until you update it on purpose. Most devices should ship this way.
Every model version can be rebuilt from versioned data, code and settings.
Results measured across patient groups, not just on average, to surface bias early.
Field monitoring spots data shift and falling accuracy, and produces the evidence reviewers ask for.
AI informs a clinical decision unless there is a cleared reason for it to act alone.
Models that adapt in the field without a plan, and outputs that act without a clinician. For data that must stay in-house, we use private AI deployment.
A submission-ready glucose monitor built to IEC 62304 and ISO 14971, with 9 percent MARD.
Health platforms we built serve more than 53 million members.
More than 70 healthcare domain experts across engineering, design and testing.
Code, design file, risk inputs, test records and traceability, assigned to you. See IP protection.
A device rarely stands alone. These are the platforms, compliance services and AI work our device projects most often plug into.
Design controls set the order, and agile sprints run inside each stage. Every project runs on Clarity, our delivery method, with records produced at each gate, not at the end.
Intended use, SaMD status and software class settled; development and test plans written; markets confirmed. Learn more.
Hazards and risk controls per ISO 14971, use-related risks per IEC 62366-1, and a threat model begun.
Segregation rationale, SOUP inventory and coding in two-week sprints, with unit tests to class and an SBOM per build.
Tests run to written protocols, usability validation is supported, a penetration test is done and the trace matrix is completed.
Release records and residual risk review, submission hand-over, field telemetry and change control.
Embedded work uses MISRA C rules, FreeRTOS, Zephyr or embedded Linux. Traceability runs in Jama Connect, Polarion or Jira with trace plugins, and SBOMs in SPDX or CycloneDX. Health data moves over FHIR R4, HL7 v2 and DICOM, and hosting runs on AWS, Azure or Google Cloud.
Medical device software usually costs from about $60,000 for a Class A SaMD MVP to $350,000 or more for Class C or complex embedded systems. Class B software with a full design file and submission sections typically costs $150,000 to $350,000.
Class A reaches a validated release in about 4 to 6 months, Class B in 8 to 14 months, and Class C or embedded work often takes 18 months or more. Regulator review time comes on top.
Safety class drives the budget, not feature count, because evidence and testing grow with class. See our full medical device software cost guide.
The biggest factor. Class C evidence and testing take several times the effort of Class A.
FDA only, or FDA plus EU MDR and UKCA, each with its own file.
Change control planning, subgroup testing and drift monitoring add scope.
Working inside a mature ISO 13485 system is faster than building one alongside.
Embedded work and several device models add firmware and test time.
Change control, patches and surveillance over the device lifetime.
Some teams need a device built from scratch. Others need a fielded product brought into a defensible state. You can also hire medical device software developers to work inside your own QMS.
Classification, risk, build, testing and release records on a fixed price, starting from an MVP when that fits the class.
For a new SaMD, device or AI product.
A gap review of code, SOUP, risk and traceability, then the work to close each gap before an audit or a new submission.
For fielded software with thin records.
A standing senior team that follows your procedures, on a monthly basis, through AI Velocity Pods.
For companies with a device roadmap.
Medical device software development is building and documenting software that is a medical device, runs inside one, or supports one. It follows IEC 62304 for the lifecycle, ISO 14971 for risk, ISO 13485 for quality and IEC 62366-1 for usability. The records are part of the product, not paperwork added later.
Classification, risk work, design, coding, testing and the records a submission needs. Our medical device software development services cover SaMD, embedded firmware, AI device software, companion apps, cloud back ends, the cybersecurity package and postmarket change control.
Five stages: classification and planning, risk and requirements, architecture and build, integration and verification, then release and postmarket. Design controls set the order, and every stage produces its own records. See our glucose monitor case study for the process in practice.
Yes, when agile runs inside the quality system. Agile in medical device development means each sprint updates requirements, risk, tests and trace links together. Formal releases still follow change control. The AAMI TIR45 guidance explains how agile maps to IEC 62304.
SaMD does a medical job on its own; SiMD runs inside a hardware device and makes it work. SaMD has its own regulatory path, while SiMD is reviewed as part of the whole device. See SaMD vs SiMD.
It depends on the worst harm a software failure could cause. Class A means no injury is possible, Class B means non-serious injury, and Class C means death or serious injury. The class comes from your hazard analysis and is set per software item.
They are separate, and you need both. The FDA class (I, II or III) reflects risk to the patient and sets your submission route. The IEC 62304 class (A, B or C) reflects what a software failure could cause and sets how much evidence you need. A Class II device can hold Class C software.
From about $60,000 for a Class A SaMD MVP to $350,000 or more for Class C or complex embedded work. Class B with a full design file usually costs $150,000 to $350,000. Safety class, not feature count, drives the price.
About 4 to 6 months for Class A, 8 to 14 months for Class B, and 18 months or more for Class C or embedded work. Regulator review time comes on top and is outside any vendor’s control.
Most SaMD with a medical claim does. The usual routes are 510(k) when a similar device exists, De Novo for new low to moderate risk devices, and PMA for the highest risk. Some low-risk software is exempt. Your regulatory lead should confirm the route before you commit.
Yes. For cyber devices we deliver a threat model, an SBOM produced by every build, a vulnerability monitoring process, signed updates and a coordinated disclosure route. These are what the FDA expects in a premarket submission.
SOUP means software of unknown provenance: third-party code not built under your quality system. IEC 62304 asks you to list each item and version, justify it, assess how it could fail and watch for new issues. We keep that list from the first commit.
A Predetermined Change Control Plan describes future model changes, and how you will test them, in your first submission. Once authorised, those changes need no new submission. It is the difference between an AI device you can improve and one frozen at clearance.
Yes, or we use our own documented process if you do not have one yet. Since February 2026 the FDA quality rule builds on ISO 13485, so one well-run system serves US and EU needs. Our work is open to your audit.
Not at the start, but you need it before verification. Early work runs on simulators, reference boards and recorded device data. Final testing must run on the real hardware, because timing, radio behaviour and power use differ.
You do. Source code, the design history file, risk inputs, test records, traceability and the usability file all assign to your company on payment. You can take them to another vendor, and we will help with the handover.
Send it over and a senior device engineer will reply, usually the same day.
Tell us the intended use, the likely class and your target markets. A senior architect will scope it and fix the price. A good medical device software development company should also tell you what it will not do.
Loading available times…
Information Security
Management System
Quality Management
System